Detalhe da pesquisa
1.
Targeting CD123 in acute myeloid leukemia using a T-cell-directed dual-affinity retargeting platform.
Blood
; 127(1): 122-31, 2016 Jan 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-26531164
2.
[(18)F]FHBG PET/CT Imaging of CD34-TK75 Transduced Donor T Cells in Relapsed Allogeneic Stem Cell Transplant Patients: Safety and Feasibility.
Mol Ther
; 23(6): 1110-1122, 2015 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-25807290
3.
Control of acute myeloid leukemia and generation of immune memory in vivo using AMV564, a bivalent bispecific CD33 x CD3 T cell engager.
PLoS One
; 19(5): e0300174, 2024.
Artigo
em Inglês
| MEDLINE | ID: mdl-38696390
4.
Targeting VLA4 integrin and CXCR2 mobilizes serially repopulating hematopoietic stem cells.
J Clin Invest
; 129(7): 2745-2759, 2019 05 14.
Artigo
em Inglês
| MEDLINE | ID: mdl-31085833
5.
An "off-the-shelf" fratricide-resistant CAR-T for the treatment of T cell hematologic malignancies.
Leukemia
; 32(9): 1970-1983, 2018 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-29483708
6.
Phase I study of azacitidine following donor lymphocyte infusion for relapsed acute myeloid leukemia post allogeneic stem cell transplantation.
Leuk Res
; 49: 1-6, 2016 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-27505705
7.
Suicide genes: monitoring cells in patients with a safety switch.
Front Pharmacol
; 5: 241, 2014.
Artigo
em Inglês
| MEDLINE | ID: mdl-25414668